Víctor Lago

ORCID: 0000-0002-2971-1899 · 2 papers in corpus

review 2026

TROP2-targeting antibody-drug conjugates in breast cancer and ovarian carcinoma: therapeutic advances and resistance mechanisms

Cancer drug resistance (Alhambra, Calif.) ·doi:10.20517/cdr.2025.195

Antibody-drug conjugates (ADCs) targeting trophoblast cell-surface antigen 2 (TROP2) have emerged as a promising therapeutic strategy for the treatment of triple-negative breast cancer (TNBC) and ovarian carcinoma, two malignancies characte…

2024

211 Ghost ileostomy after rectal resection in patients with deep infiltrating endometriosis

·doi:10.1136/ijgc-2024-esgo.495